D-1155-2019 Class II Terminated
FDA drug recall D-1155-2019 was initiated by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy on April 2, 2019 and is designated Class II. Reason for recall: Lack of sterility assurance. The recall status is terminated (terminated September 24, 2021). Affected quantity: 2 vials.
Recall Details
- Product Type
- Drugs
- Report Date
- April 24, 2019
- Initiation Date
- April 2, 2019
- Termination Date
- September 24, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2 vials
Product Description
HCG 40 Day Injection Extra Strength, vials, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
Reason for Recall
Lack of sterility assurance.
Distribution Pattern
Nationwide
Code Information
All Lots